Drugs selective for nicotinic receptor subtypes: A real possibility or a dream?

Behavioural Brain Research

Volumn 113, Issue 1-2, 2000, Pages 183-192

  Gotti, Cecilia ^a   Carbonnelle, Eric ^a   Moretti, Milena ^a   Zwart, Ruud ^b   Clementi, Francesco ^a  

^a CNR   (Italy)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Bungarotoxin; 4 Oxystilbene; Chick optic lobe; Epibatidine; Neuronal nicotinic receptors; Oocytes; Retina; Subtypes

Indexed keywords

'F 3'; BUNGAROTOXIN RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; STILBENE DERIVATIVE; STILONIUM IODIDE;

ARTICLE; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; NONHUMAN; OOCYTE; OPTIC LOBE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RETINA;

ANIMALS; BRAIN; CHICKENS; HUMANS; NICOTINIC ANTAGONISTS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RECEPTORS, NICOTINIC; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033846304     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00212-6     Document Type: Article

References (82)

1. Albuquerque E.X., Pereira E.F., Braga M.F., Alkondon M. Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors. J. Physiol. Paris. 92:1998;309-316.
2. Alkondon M., Pereira E.F., Cortes W.S., Maelicke A., Albuquerque E.X. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9:1997;2734-2742.
3. Arias H.R. Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res. Brain Res. Rev. 25:1997;133-191.
4. Arias H.R. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Bba-Rev. Biomembr. 1376:1998;173-220.
5. Badio B., Daly J.W. Epibatidine, a potent analgetic and nicotinic agonist. Mol. Pharmacol. 45:1994;563-569.
6. Bencherif M., Lovette M.E., Fowler K.W., Arrington S., Reeves L., Caldwell W.S., Lippiello P.M. RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization. J. Pharmacol. Exp. Ther. 279:1996;1413-1421.
7. Bertrand D., Devillers-Thiery A., Revah F., Galzi J.L., Hussy N., Mulle C., Bertrand S., Ballivet M., Changeux J.P. Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1261-1265.
8. Briggs C.A., Anderson D.J., Brioni J.D., Buccafusco J.J., Buckley M.J., Campbell J.E., Decker M.W., Donnelly-Roberts D., Elliott R.L., Gopalakrishnan M., Holladay M.W., Hui Y.H., Jackson W.J., Kim D.J., Marsh K.C., O'Neill A., Prendergast M.A., Ryther K.B., Sullivan J.P., Arneric S.P. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol. Biochem. Behav. 57:1997;231-241.
9. Colquhoun L.M., Patrick J.W. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv. Pharmacol. 39:1997;191-220.
10. Corriveau R.A., Berg D.K. Coexpression of multiple acetylcholine receptor genes in neurons: quantification of transcripts during development. J. Neurosci. 13:1993;2662-2671.
11. Covernton P.J., Kojima H., Sivilotti L.G., Gibb A.J., Colquhoun D. Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J. Physiol. (Lond.). 481:1994;27-34.
12. Di Angelantonio S, Nistri A, Moretti M, Clementi F, Gotti C. Antagonism of nicotinic receptors of rat chromaffin cells by N,N,N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study. Br J Pharmacol 2000: in press.
13. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U.S.A. 94:1997;587-592.
14. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
15. ++ modulation of human neuronal alpha3 nicotinic receptors. J. Pharmacol. Exp. Ther. 286:1998;311-320.
16. (3)H]chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor alpha-subunit. FEBS Lett. 253:1989;190-198.
17. Goldner F.M., Dineley K.T., Patrick J.W. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. Neuroreport. 8:1997;2739-2742.
18. Gordon J., Gurley O., Tran A., Machulskis A., Zongrone J., Luhowskj S., Ryan T., Mack R., Loch J. III, Balestra M., Decory T., Sampognaro A., Wright N., Verhoest P., Macor J., Kover A., Wu E., Griffith R., Mullen G., Murray R., Blosser J. AR-R17779: the first high affinity, subtype-selective full agonist at the rodent alpha7 nicotinic acetylcholine receptor. Soc. Neurosci. Abstr. 331:1998;9.
19. Gotti C., Hanke W., Maury K., Moretti M., Ballivet M., Clementi F., Bertrand D. Pharmacology and biophysical properties of alpha 7 and alpha 7-alpha 8 alpha-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci. 6:1994;1281-1291.
20. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog. Neurobiol. 53:1997;199-237.
21. Gotti C., Moretti M., Maggi R., Longhi R., Hanke W., Klinke N., Clementi F. Alpha7 and alpha8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci. 9:1997;1201-1211.
22. Gotti C., Balestra B., Moretti M., Rovati G.E., Maggi L., Rossoni G., Berti F., Villa L., Pallavicini M., Clementi F. 4-oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors. Br. J. Pharmacol. 124:1998;1197-1206.
23. Guo J.Z., Tredway T.L., Chiappinelli V.A. Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus. J. Neurosci. 18:1998;1963-1969.
24. Hellström-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res. Mol. Brain Res. 66:1999;94-103.
25. Holladay M.W., Dart M.J., Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40:1997;4169-4194.
26. Kem W.R. Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist. Invert. Neurosci. 3:1997;251-259.
27. Kristufek D., Stocker E., Boehm S., Huck S. Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles. J. Physiol. (Lond.). 516:1999;739-756.
28. 2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J. Neurosci. 17:1997;9035-9047.
29. Le Novère N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40:1995;155-172.
30. Le Novère N., Zoli M., Changeux J.P. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8:1996;2428-2439.
31. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22:1996;431-445.
32. Lindstrom J. The Structure of NAChRs. In: Clementi F, Fornasari D, Gotti C, editors. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology, Vol. 144. Berlin: Springer-Verlag, 2000 (in press).
33. Lloyd G.K., Menzaghi F., Bontempi B., Suto C., Siegel R., Akong M., Stauderman K., Velicelebi G., Johnson E., Harpold M.M., Rao T.S., Sacaan A.I., Chavez-Noriega L.E., Washburn M.S., Vernier J.M., Cosford N.D., McDonald L.A. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci. 62:1998;1601-1606.
34. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
35. Luetje C.W., Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
36. Lukas R.J. Diversity and patterns of regulation of nicotinic receptor subtypes. Ann. N.Y. Acad. Sci. 757:1995;153-168.
37. Lukas R.J., Changeux J.P., Le Novère N., Albuquerque E.X., Balfour D.J., Berg D.K., Bertrand D., Chiappinelli V.A., Clarke P.B., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quik M., Taylor P.W., Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51:1999;397-401.
38. MacDermott A.B., Role L.W., Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annu. Rev. Neurosci. 22:1999;443-485.
39. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
40. McIntosh JM. Toxin antagonists of the neuronal nAChR. In: Clementi F, Fornasari D, Gotti C, editors. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology, Vol. 144. Berlin: Springer-Verlag, 2000 (in press).
41. Maggi L., Palma E., Eusebi F., Moretti M., Balestra B., Clementi F., Gotti C. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor. Br. J. Pharmacol. 126:1999;285-295.
42. Mantegazza P., Tommasini R. Central antinicotinic activity of 4-oxystilbene and 4-oxydiphenylethane derivatives. Arch. Int. Pharmacodyn. CIII(4):1955;371-403.
43. Martin-Ruiz C.M., Court J.A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem. 73:1999;1635-1640.
44. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novère N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810.
45. Marubio L, Changeux JP. Knock-out animals as models for studying NAChR function. In: Clementi F, Fornasari D, Gotti C, editors. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology, Vol. 144. Berlin: Springer-Verlag, 2000 (in press).
46. 3H]nicotine as an agonist photoaffinity label. Biochemistry. 30:1991;6987-6997.
47. 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J. Neural. Transm. Park. Dis. Dement. Sect. 2:1990;215-224.
48. Nordberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31:1992;103-111.
49. Nordberg A. Neuronal nicotinic receptors and their implications in ageing and neurodegenerative disorders in mammals. J. Reprod. Fertil. Suppl. 46:1993;145-154.
50. Ohana B., Gershoni J.M. Comparison of the toxin binding sites of the nicotinic acetylcholine receptor from Drosophila to human. Biochemistry. 29:1990;6409-6415.
51. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J. Physiol. (Lond.). 491:1996;151-161.
52. Papke R.L. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog. Neurobiol. 41:1993;509-531.
53. Papke R.L., Bencherif M., Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci. Lett. 213:1996;201-204.
54. Papke R.L., Thinschmidt J.S., Moulton B.A., Meyer E.M., Poirier A. Activation and inhibition of rat neuronal nicotinic receptors by ABT-418. Br. J. Pharmacol. 120:1997;429-438.
55. Parker M.J., Beck A., Luetje C.W. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity. Mol. Pharmacol. 54:1998;1132-1139.
56. Paton W.D.M., Zaimis E.J. The pharmacological actions of polymethylene bistrimethylammonium salts. Br. J. Pharmacol. 4:1949;381-400.
57. Paton W.D.M., Zaimis E.J. Paralysis of autonomic ganglia by methonium salts. Br. J. Pharmacol. 6:1951;155-168.
58. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., Le Novère N., Vincent P., Merlo Pich E., Brûlet P., Changeux J.P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 374:1995;65-67.
59. Poth K., Nutter T.J., Cuevas J., Parker M.J., Adams D.J., Luetje C.W. Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia. J. Neurosci. 17:1997;586-596.
60. Radcliffe K.A., Fisher J.L., Gray R., Dani J.A. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann. N.Y. Acad. Sci. 868:1999;591-610.
61. Rubboli F., Court J.A., Sala C., Morris C., Perry E., Clementi F. Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem. Int. 25:1994;69-71.
62. Rubboli F., Court J.A., Sala C., Morris C., Chini B., Perry E., Clementi F. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6:1994;1596-1604.
63. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
64. Sivilotti L.G., McNeil D.K., Lewis T.M., Nassar M.A., Schoepfer R., Colquhoun D. Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J. Physiol. (Lond.). 500:1997;123-138.
65. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11:1995;201-203.
66. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6:1997;943-947.
67. Unwin N. Nicotinic acetylcholine receptor at 9 Å resolution. J. Mol. Biol. 229:1993;1101-1124.
68. Unwin N. Projection structure of the nicotinic acetylcholine receptor: distinct conformations of the alpha subunits. J. Mol. Biol. 257:1996;586-596.
69. Vailati S., Hanke W., Bejan A., Barabino B., Longhi R., Balestra B., Moretti M., Clementi F., Gotti C. Functional alpha6-containing nicotinic receptors are present in chick retina. Mol. Pharmacol. 56:1999;11-19.
70. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
71. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J. Biol. Chem. 271:1996;17656-17665.
72. Weiland S., Witzemann V., Villarroel A., Propping P., Steinlein O. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett. 398:1996;91-96.
73. Wess J., Buhl T., Lambrecht G., Mutschler E. Cholinergic receptors. Hansch C., Sammes P.G., Taylor J.B. Comprehensive Medicinal Chemistry: The Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds. 3:1990;423-491 Pergamon Press, Oxford.
74. Wevers A., Monteggia L., Nowacki S., Bloch W., Schütz U., Lindstrom J., Pereira E.F.R., Eisenberg H., Giacobini E., de Vos R.A.I., Jansen Steur E.N.H., Maelicke A., Albuquerque E.X., Schröder H. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur. J. Neurosci. 11:1999;2551-2565.
75. Wonnacott S, Albuquerque EX, Bertrand D. Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses. In: Conn PM, editor. Methods in Neurosciences, Vol. 12: Receptors: Molecular Biology, Receptor Subclasses, Localization and Ligand Binding. New York: Academic Press, 1993. pp.263-275.
76. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
77. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., Beaudet A.L. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5746-5751.
78. Yu C.R., Role L.W. Functional contribution of the alpha7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones. J. Physiol. (Lond.). 509:1998;651-665.
79. Zaimis E. Neuromuscular function. Handbook of Experimental Pharmacology, Vol. 42. Berlin: Springer-Verlag, 1976.
80. Zoli M. NAChR in development and ageing. In: Clementi F, Fornasari D, Gotti C, editors. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology, Vol. 144. Berlin: Springer-Verlag, 2000 (in press).
81. Zwart R., Vijverberg H.P. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol. Pharmacol. 52:1997;886-895.
82. Zwart R., Vijverberg H.P. Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol. Pharmacol. 54:1998;1124-1131.